Haplotypes of variants in the UDP-glucuronosyltransferase 1A9 and 1A1 genes

被引:97
作者
Innocenti, F
Liu, WQ
Chen, PX
Desai, AA
Das, S
Ratain, MJ
机构
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Human Genet, Comm Clin Pharmcol & Pharmacogenom, Chicago, IL 60637 USA
[3] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
关键词
UGT1A1; UGT1A9; haplotypes; SN-38; irinotecan;
D O I
10.1097/01213011-200505000-00004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives Nine different functional UGT1 A enzymes are generated from a single UGT1A gene by alternative splicing, with each enzyme having a unique exon 1. SN-38, the active metabolite of the anticancer agent irinotecan, is metabolized by both UGT1A1 and UGT1A9. We aim to characterize the UGT1A9-UGT1A1 haplotypes in Asians and Caucasians and gain insights on their functional consequences. Methods Asian and Caucasian individuals were genotyped for UGT1A1 and UGT1A9 variants. Results A higher frequency of the UGT1A9 -118T(10) allele was observed in Asians compared to Caucasians, while the -275T>A and -2152C>T variants were relatively uncommon in Caucasians and not found in Asians. The strongest linkage disequilibrium (LID) was observed between the UGT1A1 -53 and -3156 and between the UGT1A9 - 275 and - 2152 loci. Lower LD was observed between the - 118 UGT1A9 variant and the UGT1A 1 variants. Fourteen UGT1A9-UGT1A1 haplotypes were found in Asians, seven of them found to be shared by both populations. Common UGT1A9-UGT1A1 diplotypes were defined, and a difference was observed across the SN-38 glucuronidation rates in Caucasian livers stratified by diplotypes. Conclusion This study for the first time described common UGT1A9-UGT1A1 haplotypes, highlighting important ethnic differences between Asians and Caucasians. If the functional effect of these haplotypes can be confirmed, this haplotypic information would be applicable to the correct design of prospective clinical studies of irinotecan, as well as of other drugs primarily metabolized by both UGT1A1 and UGT1A9. (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 20 条
[1]  
Ando Y, 2000, CANCER RES, V60, P6921
[2]  
[Anonymous], BIOTECHNIQUES
[3]   Modulation of non-templated nucleotide addition by taq DNA polymerase: Primer modifications that facilitate genotyping [J].
Brownstein, MJ ;
Carpten, JD ;
Smith, JR .
BIOTECHNIQUES, 1996, 20 (06) :1004-+
[4]   UDP glucuronosyltransferase mRNA levels in human liver disease [J].
Congiu, M ;
Mashford, ML ;
Slavin, JL ;
Desmond, PV .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (02) :129-134
[5]   Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) [J].
Gagné, JF ;
Montminy, V ;
Belanger, P ;
Journault, K ;
Gaucher, G ;
Guillemette, C .
MOLECULAR PHARMACOLOGY, 2002, 62 (03) :608-617
[6]   Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver [J].
Girard, H ;
Court, MH ;
Bernard, O ;
Fortier, LC ;
Villeneuve, L ;
Hao, Q ;
Greenblatt, DJ ;
von Moltke, LL ;
Perussed, L ;
Guillemette, C .
PHARMACOGENETICS, 2004, 14 (08) :501-515
[7]   Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin [J].
Hanioka, N ;
Ozawa, S ;
Jinno, H ;
Ando, M ;
Saito, Y ;
Sawada, J .
XENOBIOTICA, 2001, 31 (10) :687-699
[8]   Variations of the bilirubin uridine-diphosyphoglucuronosyl transferase 1A1 gene in healthy Taiwanese [J].
Huang, CS ;
Luo, GA ;
Huang, MJ ;
Yu, SC ;
Yang, SS .
PHARMACOGENETICS, 2000, 10 (06) :539-544
[9]   Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan [J].
Innocenti, F ;
Undevia, SD ;
Iyer, L ;
Chen, PX ;
Das, S ;
Kocherginsky, M ;
Karrison, T ;
Janisch, L ;
Ramírez, J ;
Rudin, CM ;
Vokes, EE ;
Ratain, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1382-1388
[10]   Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups [J].
Innocenti, F ;
Grimsley, C ;
Das, S ;
Ramírez, J ;
Cheng, C ;
Kuttab-Boulos, H ;
Ratain, MJ ;
Di Rienzo, A .
PHARMACOGENETICS, 2002, 12 (09) :725-733